De novo Design of a Peptide Modulator to Reverse Sodium Channel Dysfunction Linked to Cardiac Arrhythmias and Epilepsy
Ryan W. Mahling, Bence Hegyi, Erin R. Cullen, Timothy M. Cho, Aaron Rodriques, Lucile Fossier, Mohamad Yehya, Lin Yang, Bi-Xing Chen, Alexander N. Katchman, Nourdine Chakouri, Ruiping Ji, Elaine Y. Wan, Jared Kushner, Steven O. Marx, , Manu Ben Johny
This study designs a de novo peptide modulator, ELIXIR, that inhibits pathogenic late sodium current in NaV channels, reversing dysfunction in cardiac arrhythmias and epilepsy models.
Cell · Aug 18, 2025Peer-reviewedBiophysics